REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.40
Bid: 4.12
Ask: 4.70
Change: 0.94 (27.09%)
Spread: 0.58 (14.078%)
Open: 3.64
High: 4.80
Low: 3.64
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Approval for Sale of Harpin aß Granted in Poland

1 Aug 2023 07:00

RNS Number : 8199H
Plant Health Care PLC
01 August 2023
 

RNS

01 August 2023

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Approval for Sale of Harpin αβ Granted in Poland

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that Harpin αβ, the Company's core, high-value fertilizer product with biostimulant properties, has successfully achieved Mutual Recognition in Poland. This is a major milestone for the Company, and permits immediate sales of Harpin αβ in Poland. Poland is the sixth largest agricultural producer in the EU, and the second largest potato producer behind Germany, growing around 322,000 hectares.

 

Following the initial regulatory approval in France in October 2022, Plant Health Care has pursued Mutual Recognition to expand the use of Harpin αβ across Europe and Poland is the first EU country to grant this status for Harpin αβ.. Europe is the world's largest market for sustainable agriculture with annual sales of over $2 billion.

 

Harpin αβ is a recombinant protein that acts as a powerful biostimulant, improving the yield and quality of crops. Plant Health Care is launching Harpin αβ for use in European potato production, followed by fruit and vegetable crops. Potato field trials are currently underway in Germany, France, Belgium and the Netherlands to demonstrate the value of Harpin αβ. The Company sells Harpin αβ through specialist distributors around the world. Visits to the field trials with interested distributors to observe the results of Harpin αβ on treated potato plants are planned for mid-August.

 

Angel Marin, Director EMEAA for Plant Health Care, said: ‟Expanding the use of our core product, Harpin αβ, in Europe's biggest agricultural markets has been a long-term goal of mine. The granting of Mutual Recognition by Poland brings us one-step closer and the Company expects to select our distribution partner for France, Poland and other EU countries by the end of the year. Harpin αβ is an environmentally friendly, and proven protein technology which improves plant growth and development resulting in higher quality, yields and long-term storage stability, which are vital as the world becomes more concerned about food security."

 

For further information, please contact: 

 Plant Health Care plc  Jeff Tweedy, CEO

 

+1 919 926 1600

 Cenkos Securities plc - Nomad & Broker  Neil McDonald / Pete Lynch

 

+44 (0) 131 220 9771

 SEC Newgate (Financial Communications)  Robin Tozer / Harry Handyside / George Esmond

+44 (0)7540 106 366 phc@secnewgate.co.uk

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. 

 

Find out more at www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFLLXXDLZBBK
Date   Source Headline
27th Apr 201211:49 amRNSResearch Agreement with Arysta LifeScience
25th Apr 20122:45 pmRNSTR-1 Notification of Major Interest in Shares
20th Apr 20123:00 pmRNSTR-1 Notification of Major Interest in Shares
20th Apr 20127:00 amRNSResult of AGM
18th Apr 20127:00 amRNSTR-1 Notification of Major Interest in Shares
17th Apr 20128:23 amRNSDirector/PDMR Shareholding
13th Apr 20122:00 pmRNSDirectorate Change
5th Apr 20127:00 amRNSAgreement with MANA Crop Protection
23rd Mar 201210:30 amRNSHolding(s) in Company
21st Mar 20123:00 pmRNSHolding(s) in Company
19th Mar 20129:45 amRNSPublication of Annual Report
27th Feb 20129:30 amRNSChange of Adviser
27th Feb 20127:00 amRNSFinal Results
20th Feb 20121:30 pmRNSBlocklisting Interim Review
1st Feb 20127:00 amRNSDistribution deal with Agrium subsidiary
18th Jan 20127:00 amRNSTrading Update
11th Jan 201212:10 pmRNSHolding(s) in Company
3rd Jan 20124:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20124:35 pmRNSPrice Monitoring Extension
12th Dec 20117:00 amRNSProduct Update: Harpin
1st Dec 201112:45 pmRNSTotal Voting Rights
23rd Nov 20114:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20114:35 pmRNSPrice Monitoring Extension
10th Nov 20116:00 pmRNSHolding(s) in Company
10th Nov 20114:30 pmRNSHolding(s) in Company
14th Sep 20117:30 amRNSHolding(s) in Company
13th Sep 201111:00 amRNSHolding(s) in Company
8th Sep 20114:00 pmRNSHolding(s) in Company
1st Sep 201110:30 amRNSTotal Voting Rights
1st Sep 20118:00 amRNSStatement re Jeremy Scudamore
22nd Aug 201110:00 amRNSPosting of Interim Report
19th Aug 201110:30 amRNSBLOCK LISTING SIX-MONTHLY RETURN
17th Aug 201110:40 amRNSAdditional Listing and Directors' Shareholdings
15th Aug 20117:00 amRNSHalf Yearly Report
28th Jul 20114:30 pmRNSHolding(s) in Company
1st Jun 20115:00 pmRNSHolding(s) in Company
27th May 20113:00 pmRNSHolding(s) in Company
26th May 20117:00 amRNSTrading Update
14th Apr 20112:51 pmRNSResult of AGM
7th Apr 201110:00 amRNSHolding(s) in Company
21st Mar 201112:00 pmRNSAnnual Financial Report and Notice of AGM
1st Mar 201110:15 amRNSTotal Voting Rights
24th Feb 201110:30 amRNSReplacement Director/PDMR Shareholding
23rd Feb 20111:30 pmRNSDirector/PDMR Shareholding
22nd Feb 201112:15 pmRNSDirector/PDMR Shareholding
21st Feb 20117:01 amRNSFinal Results
18th Feb 20113:00 pmRNSBlocklisting Interim Review
14th Jan 20117:00 amRNSDisposal and Trading Update
12th Jan 20115:30 pmRNSHolding(s) in Company
15th Dec 20102:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.